Laure Michel, Marion Salou, Alexandra Garcia, Nicolas Degauque, Anne Salmon, et al.. Natalizumab alters the TCR repertoire after one year of treatment in four MS patients.
6th european workshop on immune-mediated inflammatory diseases, Nice, France. pp.P26.
⟨inserm-00643971⟩